PATENT CLAIM ANALYSIS

Application Number: 15745273
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "184100"]

Abstract:
The present invention relates to methods and pharmaceutical compositions of inducing immune tolerance by mucosal vaccination with Fc-coupled antigens. In particular, the present invention relates to a method for inducing tolerance to one antigen of interest in a subject in need thereof, comprising the mucosal administration to the subject of a therapeutically effective amount of a recombinant chimeric construct comprising a FcRn targeting moiety and an antigen-containing moiety.

Claim (Index 7):
The method of  claim 1  wherein the subject is predisposed or believed to be predisposed to developing, or has already developed or is developing an immune reaction against molecules that are exogenously administered for therapeutic or other purposes.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15039524', '14961938', '12932310', '15763566', '12043769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7143851286291499
- 35 USC 102 Novelty (BERT): 0.4995355966457613
- Combined Prediction Score: 0.6929001754308111
- Mean Citation Score: 210.949178
- Max Citation Score: 231.70863
- Similarity Product: 160.39114557742775

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test